3-(4-oxocyclohexyl)-1H-indole-5-carbonitrile → 8-{4-[4-(5-Cyano-1H-indol-3-yl)-cyclohexyl]-[1,4]diazepan-1-yl}-quinoline
반응식
[N:1]1([c:8]2[cH:9][cH:10][cH:11][c:12]3[cH:13][cH:14][cH:15][n:16][c:17]23)[CH2:2][CH2:3][NH:4][CH2:5][CH2:6][CH2:7]1.[O:18]=[C:19]1[CH2:20][CH2:21][CH:22]([c:25]2[cH:26][nH:27][c:28]3[cH:29][cH:30][c:31]([C:34]#[N:35])[cH:32][c:33]23)[CH2:23][CH2:24]1>>[N:1]1([c:8]2[cH:9][cH:10][cH:11][c:12]3[cH:13][cH:14][cH:15][n:16][c:17]23)[CH2:2][CH2:3][N:4]([CH:19]2[CH2:20][CH2:21][CH:22]([c:25]3[cH:26][nH:27][c:28]4[cH:29][cH:30][c:31]([C:34]#[N:35])[cH:32][c:33]34)[CH2:23][CH2:24]2)[CH2:5][CH2:6][CH2:7]1참가 물질
3
출처 및 근거
- ORD 기록
- ord-b593d6aa49284c08b4727536052d783b
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (4/10)
반응 노트
불러오는 중…